Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Elizabeth Griffith

Adolescent Medicine Atlanta, GA Medical Doctor

NPI 1346245867 CMS profile 197401

105 Collier Rd Nw, Ste 4060, Atlanta, GA 30309

Open in the dashboard

General payments

$2,761

140 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elizabeth Griffith of Atlanta, GA is reported in the CMS Open Payments database as having received $2,761 across 140 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Adolescent Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $483 23
2024 General $530 23
2023 General $407 19
2022 General $453 23
2021 General $504 29
2020 General $140 7
2019 General $245 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elizabeth Griffith
  • Adolescent Medicine median
  • Middle half of Adolescent Medicine
  • National median

In program year 2025, general payments to Elizabeth Griffith were reported at $483. Among 914 Adolescent Medicine profiles paid that year, the median was $100 and the middle half received between $40 and $207.

Show as a table
Year Elizabeth Griffith Adolescent Medicine median Middle half National median
2019 $245 $95 $36–$198 $163
2020 $140 $50 $23–$111 $114
2021 $504 $67 $27–$179 $132
2022 $453 $79 $29–$189 $149
2023 $407 $100 $39–$194 $160
2024 $530 $93 $38–$195 $164
2025 $483 $100 $40–$207 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $381 15 payments
  2. Tris Pharma Inc $360 19 payments
  3. Cranial Technologies, Inc $286 15 payments
  4. Sanofi-Aventis U.S. LLC $255 11 payments
  5. kaleo, Inc. $239 15 payments
  6. Pfizer Inc. $195 10 payments
  7. Ironshore Pharmaceuticals Inc. $167 9 payments
  8. Supernus Pharmaceuticals, Inc. $149 7 payments
  9. GlaxoSmithKline, LLC. $103 6 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $91 5 payments
  11. Other $535 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,685 138 payments
  2. Gift $48 1 payment
  3. Long term medical supply or device loan $29 1 payment
Products named General payments · program years 2019–2025
  1. Azstarys $381 15 payments
  2. Doc Band $286 15 payments
  3. TZIELD $255 11 payments
  4. AUVI-Q $198 12 payments
  5. COMIRNATY $153 7 payments
  6. QELBREE $131 6 payments
  7. Dyanavel XR $105 3 payments
  8. BEXSERO $103 6 payments
  9. VYVANSE $99 5 payments
  10. PREVNAR 20 $98 4 payments
  11. Other $1,292 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adolescent Medicine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record